← News
Stocks· July 18, 2026 at 01:50 PM
Should You Buy Viking Therapeutics Stock on the Dip? Wall Street Is Screaming "Yes."
Authored by·Editorially reviewed
Onur Erkan YıldızFounder, Financial Engineer · CMB-licensed
Higher education in Financial Engineering and Money & Capital Markets. SPK (Turkey CMB) licence. 16 years across institutional markets, research, and quant-driven analytics.
NeutralMedium impact
AI summary
Wall Street analysts are highly bullish on Viking Therapeutics, not least because of its promising weight-loss drug, with ongoing and upcoming phase 3 trials.
Affected symbols
AI commentary is generated from public news feeds and is not investment advice.
Related coverage
StocksMedium impactNeutral2h
Better Buy: SK Hynix vs. Micron
via Yahoo Finance
NVDA
StocksMedium impactNeutral3h
Amazon’s $25 Billion Bond Sale Created 3 More Reasons for Me to Keep Buying
via Yahoo Finance
MSFT
StocksMedium impactNeutral3h
This week's AI winners and losers
via Yahoo Finance
AAPL
StocksMedium impactNeutral3h
TSMC: Stock to Avoid or Incredible Buying Opportunity? (NYSE: TSM)
via Yahoo Finance
NVDA